A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
Clinical trial NCT03148691 · COMPLETED
Trial details
- NCT number
- NCT03148691
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2018-02-28
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.